Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Osteoporosis in Cystic Fibrosis
NCT03921060Phase 4Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Sep 2021
- Primary completion
- Jul 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in osteoporosis, sponsored by UT Southwestern Medical Center. Started Sep 2021; status: recruiting.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03921060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03921060.